COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 194

Emailed: 0

PDF Downloaded: 103

International Journal of Clinical Biochemistry and Research

Role of non-HDL-cholesterol in evaluation of dyslipidemia in preeclampsia

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Reena R*, S M R Usha, B M Rupakala, H V Shetty

Volume : 6, Issue : 3, Year : 2019

Article Page : 369-374

Suggest article by email


Introduction: Physiological changes in lipid metabolism observed during pregnancy is exaggerated in
preeclampsia (PE). The latest recommendations of European and American Cardiological Associations
and National Cholesterol Education Program Adult treatment panel III (NCEP ATP III), emphasize the
role of non-High-Density Lipoprotein cholesterol (non-HDL-C) in evaluating the risk of atherogenesis, as
a marker of dyslipidemia, especially in presence of hypertriglyceridemia. The aim of this study was to
measure non-HDL-C to assess dyslipidemia in PE, a state of hypertriglyceridemia.
Materials and Methods: Study was conducted on fifty preeclamptic women and fifty age matched
apparently healthy pregnant women attending the Antenatal clinic in Department of Obstetrics and
Gynecology, Rajarajeswari Medical College and Hospital. Lipid profile was estimated in Erba auto
analyzer EM 360 by enzymatic method and Non-HDL-C was calculated by subtracting HDL-C from Total
cholesterol (TC).
Results: Hypertriglyceridemia was observed in both the groups. Serum non-HDL-C level was
161.7644.74 mg/dl and 143.7521.80 mg/dl in cases and controls respectively. Non-HDL-C was
increased moderately (p<0> compared to controls. Despite of normal LDL-C, High non-HDL-C was observed in five preeclamptic
women (12%).
Conclusion: Dyslipidemia is observed in PE which results in atherogenesis and endothelial dysfunction.
Non-HDL-C predicts dyslipidemia better than LDL-C in PE. The health of the mother and her fetus
are intertwined, hence the non-HDL-C should be recommended to be a part of routine investigation
during pregnancy, to institute prompt management strategies to prevent deleterious effects of dyslipidemia
associated with PE.

Keywords: Atherogenesis, Dyslipidemia, Lipid profile, Non-HDL-C, Preeclampsia.

Doi : 10.18231/j.ijcbr.2019.080

How to cite : Reena R, Usha S M R, Rupakala B M, Shetty H V, Role of non-HDL-cholesterol in evaluation of dyslipidemia in preeclampsia. Int J Clin Biochem Res 2019;6(3):369-374

Copyright © 2019 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (